Knowledge mapping and current trends of global research on snoRNA in the field of cancer

Author:

Xu Runsen1,Hou Junhui1,Wang Xia1,Wang Yuan1,Wang Kefeng1

Affiliation:

1. Shengjing Hospital of China Medical University

Abstract

Abstract Backgroud: Cancer is a major hazard to human health. Recently, small nucleolar RNA (snoRNA) has been found to be involved in the occurrence and development of cancer, which has potential diagnostic, prognostic and therapeutic value. The purpose of this study is to use the bibliometrics method to sort out and study the previous published papers. Methods We collected articles from the Web of Science Core Collection database in the field of snoRNA and cancer. Then, we used VOSviewer, Citespace, WPS and other software to visualize authors, Finally, we interpreted the data and analyzed the hotspots and frontiers of the research. Results The number of articles in this field was low in the early period, but exploded since 2008. According to the calculation of Prince's law, we believed that a stable cooperative group had been formed in this field. Chu, Liang and Montanaro, Lorenzo published the most papers, while Jiang, Feng were cited the most times. Three institutions published the most articles, namely Wuhan Univ, China Med Univ and Guangxi Med Univ. The journal with the most articles was Oncotarget. Through the analysis of countries/regions, it was found that the country with the most published articles was China. The analysis of keywords and burst words indicated that early studies mainly focused on the molecular mechanisms, but in recent years, it has gradually shifted to the direction of diagnosis, prognosis and therapy. Conclusion The research of snoRNA and cancer was a hot topic in recent years. Through analysis, we found that snoRNA was involved in the molecular mechanism of cancer development and can be used as a biomarker for clinical diagnosis and prognosis.

Publisher

Research Square Platform LLC

Reference48 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;Ca-a Cancer Journal for Clinicians,2021

2. "Cancer statistics, 2022." Ca-a Cancer;Siegel RL;J Clin,2022

3. "Cancer Statistics in China, 2015." Ca-a Cancer;Chen WQ;J Clin,2016

4. An updated human snoRNAome.;Jorjani H;Nucleic Acids Res,2016

5. Are snoRNAs and snoRNA host genes new players in cancer?;Williams GT;Nat Rev Cancer,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3